Pregled bibliografske jedinice broj: 985988
Autonomic symptom burden can predict disease activity in early multiple sclerosis
Autonomic symptom burden can predict disease activity in early multiple sclerosis // Multiple Sclerosis and Related Disorders, 28 (2019), 250-255 doi:10.1016/j.msard.2019.01.005 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 985988 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Autonomic symptom burden can predict disease activity in early multiple sclerosis
Autori
Krbot Skorić, Magdalena ; Crnošija, Luka ; Gabelić, Tereza ; Barun, Barbara ; Adamec, Ivan ; Junaković, Anamari ; Pavičić, Tin ; Ruška, Berislav ; Habek, Mario
Izvornik
Multiple Sclerosis and Related Disorders (2211-0348) 28
(2019);
250-255
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
autonomic nervous system ; COMPASS-31 ; MRI ; multiple sclerosis
Sažetak
BACKGROUND: We aimed to evaluate the role of autonomic nervous system (ANS) abnormalities on disease activity (relapses and new MRI lesions) and disease progression in people with clinically isolated syndrome (pwCIS). METHODS: Out of 121 consecutive pwCIS, data on disease activity and progression after 2.9 (1.4-4.1) years of follow-up, was available for 94 pwCIS. Baseline characteristics included MRI parameters, Composite Autonomic System Score-31 (COMPASS-31), Composite Autonomic Scoring Scale, and supine and standing levels of epinephrine and norepinephrine. RESULTS: Univariable logistic regression analysis revealed three predictors for occurrence of new relapse, COMPASS-31 > 7.32, total number of T2 lesions > 3 and decreasing supine level of epinephrine. The Kaplan-Meier survival analysis showed that patients with COMPASS-31 > 7.32 have statistically significant lower probability that they will be relapse free (p = 0.013). It has also showed that the relative risk reduction for occurrence of new relapse in participants with COMPASS < 7.32 was 46%. The multivariable regression model confirmed that COMPASS-31 > 7.32 and total number of T2 lesions > 3 increase the likelihood and the increasing supine level of epinephrine reduces the likelihood for a relapse. Finally, results of the Cox regression analysis showed, that after controlling for age, sex, total number of T2 lesions > 3 and supine level of epinephrine, the hazard for occurrence of new relapse for participants with COMPASS-31 > 7.32 is 2.7 times that of participants with COMPASS- 31 < 7.32. CONCLUSION: This study provides evidence that ANS is an important contributor to development of disease activity in pwCIS.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
HRZZ-UIP-11-2013-2622
Ustanove:
Fakultet elektrotehnike i računarstva, Zagreb,
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
MAGDALENA KRBOT SKORIĆ
(autor)
Mario Habek
(autor)
Tereza Gabelić
(autor)
Berislav Ruška
(autor)
Anamari Junaković
(autor)
Ivan Adamec
(autor)
Barbara Barun
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE